A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Clinical trial NCT06730750 · RECRUITING

Trial details

NCT number: NCT06730750
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-02-12
Primary completion: 2026-09-05
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.